Header Logo

Connection

RAJKUMAR VENKATRAMANI to Child, Preschool

Back to Details
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Child, Preschool.
RAJKUMAR VENKATRAMANI
Connection Strength
1.848
Child, Preschool
  1. Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies. Pediatr Blood Cancer. 2024 Oct; 71(10):e31200.
    View in: PubMed
    Score: 0.074
  2. Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group. Lancet Oncol. 2024 Jul; 25(7):912-921.
    View in: PubMed
    Score: 0.074
  3. Synovial Sarcoma in Children, Adolescents, and Young Adults: A Report From the Children's Oncology Group ARST0332 Study. J Clin Oncol. 2021 12 10; 39(35):3927-3937.
    View in: PubMed
    Score: 0.061
  4. Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer. 2021 08; 45(4):100768.
    View in: PubMed
    Score: 0.060
  5. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma. J Pediatr Hematol Oncol. 2021 03 01; 43(2):e195-e197.
    View in: PubMed
    Score: 0.059
  6. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2021 04; 68(4):e28914.
    View in: PubMed
    Score: 0.058
  7. Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer. 2021 03; 68(3):e28778.
    View in: PubMed
    Score: 0.057
  8. Systemic bevacizumab for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2020 Nov; 138:110352.
    View in: PubMed
    Score: 0.057
  9. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 01; 182(1):224-228.
    View in: PubMed
    Score: 0.054
  10. Malignant melanoma incidence among children and adolescents in Texas and SEER 13, 1995-2013. Pediatr Blood Cancer. 2019 06; 66(6):e27648.
    View in: PubMed
    Score: 0.051
  11. A Multicenter Retrospective Review of Pediatric Leydig Cell Tumor of the Testis. J Pediatr Hematol Oncol. 2019 01; 41(1):74-76.
    View in: PubMed
    Score: 0.050
  12. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma. Thyroid. 2018 11; 28(11):1450-1454.
    View in: PubMed
    Score: 0.050
  13. Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma. Pediatr Blood Cancer. 2019 01; 66(1):e27469.
    View in: PubMed
    Score: 0.050
  14. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 10; 65(10):e27291.
    View in: PubMed
    Score: 0.049
  15. Alveolar soft part sarcoma in children and young adults: A report of 69 cases. Pediatr Blood Cancer. 2018 05; 65(5):e26953.
    View in: PubMed
    Score: 0.047
  16. Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials. Pediatr Blood Cancer. 2017 Jul; 64(7).
    View in: PubMed
    Score: 0.044
  17. Juvenile Granulosa Cell Tumor of the Ovary: A Clinicopathologic Study. J Pediatr Adolesc Gynecol. 2017 Feb; 30(1):138-143.
    View in: PubMed
    Score: 0.043
  18. Multimodality Treatment of Pediatric Esthesioneuroblastoma. Pediatr Blood Cancer. 2016 Mar; 63(3):465-70.
    View in: PubMed
    Score: 0.040
  19. Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e356-60.
    View in: PubMed
    Score: 0.040
  20. Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis. Am J Clin Oncol. 2014 Dec; 37(6):592-6.
    View in: PubMed
    Score: 0.038
  21. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg. 2015 Jan; 102(1):108-13.
    View in: PubMed
    Score: 0.038
  22. Images in clinical medicine. Langerhans'-cell histiocytosis. N Engl J Med. 2014 Sep 11; 371(11):1050.
    View in: PubMed
    Score: 0.037
  23. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin. Pediatr Blood Cancer. 2014 Sep; 61(9):1679-84.
    View in: PubMed
    Score: 0.036
  24. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children. Pediatr Blood Cancer. 2014 Aug; 61(8):1357-61.
    View in: PubMed
    Score: 0.036
  25. Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation. Pediatr Pulmonol. 2015 Jun; 50(6):596-603.
    View in: PubMed
    Score: 0.036
  26. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatr Blood Cancer. 2014 Jul; 61(7):1277-81.
    View in: PubMed
    Score: 0.036
  27. Inflammatory myofibroblastic tumors in childhood. Pediatr Hematol Oncol. 2013 Oct; 30(7):640-5.
    View in: PubMed
    Score: 0.035
  28. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One. 2013; 8(7):e68416.
    View in: PubMed
    Score: 0.035
  29. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):942-8.
    View in: PubMed
    Score: 0.034
  30. Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial. J Neurooncol. 2013 Jun; 113(2):285-91.
    View in: PubMed
    Score: 0.034
  31. A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors. Pediatr Blood Cancer. 2013 Jul; 60(7):1103-7.
    View in: PubMed
    Score: 0.033
  32. Pleuropulmonary blastoma: a single-institution experience. J Pediatr Hematol Oncol. 2012 Jul; 34(5):e182-5.
    View in: PubMed
    Score: 0.032
  33. An exploratory epidemiological study of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2012 Dec 15; 59(7):1324-6.
    View in: PubMed
    Score: 0.031
  34. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. Pediatr Blood Cancer. 2012 Sep; 59(3):493-8.
    View in: PubMed
    Score: 0.031
  35. Supratentorial ependymoma in children: to observe or to treat following gross total resection? Pediatr Blood Cancer. 2012 Mar; 58(3):380-3.
    View in: PubMed
    Score: 0.029
  36. Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer. 2024 Nov; 71(11):e31303.
    View in: PubMed
    Score: 0.019
  37. The impact of margins and re-resection in pediatric synovial sarcoma. Cancer Med. 2024 Sep; 13(17):e70207.
    View in: PubMed
    Score: 0.019
  38. Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2024 Jul; 71(7):e31009.
    View in: PubMed
    Score: 0.018
  39. Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group. Cancer. 2024 Jul 15; 130(14):2493-2502.
    View in: PubMed
    Score: 0.018
  40. Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group. Cancer. 2023 06 01; 129(11):1735-1743.
    View in: PubMed
    Score: 0.017
  41. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study. Lancet Oncol. 2021 09; 22(9):1312-1321.
    View in: PubMed
    Score: 0.015
  42. Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer Med. 2021 02; 10(3):857-866.
    View in: PubMed
    Score: 0.014
  43. Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups. Pediatr Blood Cancer. 2021 03; 68(3):e28832.
    View in: PubMed
    Score: 0.014
  44. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. 2021 03 15; 127(6):946-956.
    View in: PubMed
    Score: 0.014
  45. Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2021 01 15; 127(2):275-283.
    View in: PubMed
    Score: 0.014
  46. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 01; 68(1):e28741.
    View in: PubMed
    Score: 0.014
  47. Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.
    View in: PubMed
    Score: 0.014
  48. Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):e12-e18.
    View in: PubMed
    Score: 0.012
  49. Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.012
  50. Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution. Histopathology. 2017 Nov; 71(5):813-822.
    View in: PubMed
    Score: 0.012
  51. Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III. Pediatr Blood Cancer. 2017 Oct; 64(10).
    View in: PubMed
    Score: 0.011
  52. Myofibroma in Infancy and Childhood. J Pediatr Hematol Oncol. 2017 04; 39(3):e136-e139.
    View in: PubMed
    Score: 0.011
  53. The diagnostic and prognostic value of SALL4 in hepatoblastoma. Histopathology. 2016 Nov; 69(5):822-830.
    View in: PubMed
    Score: 0.011
  54. Zoledronic Acid for the Treatment of Children With Refractory Central Giant Cell Granuloma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e399-401.
    View in: PubMed
    Score: 0.010
  55. Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma. Pediatr Hematol Oncol. 2015 Feb; 32(1):26-31.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.